Endocyte Inc (ECYT) Financial Statements (2024 and earlier)
Company Profile
Business Address |
3000 KENT AVE STE A1-100 WEST LAFAYETTE, IN 47906 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2018 MRQ | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 97,471 | 138,207 | 173,600 | 125,070 | 123,281 | 175,838 | |||
Cash and cash equivalents | 18,559 | 31,228 | 15,432 | 45,533 | 52,847 | 33,997 | |||
Short-term investments | 78,912 | 106,979 | 158,169 | 79,536 | 70,434 | 141,841 | |||
Receivables | 273 | 55 | 9 | 706 | 6,353 | 5,689 | |||
Prepaid expense | 751 | 1,737 | 773 | 610 | 3,201 | ✕ | |||
Other current assets | 77 | 256 | 494 | 653 | 496 | ✕ | |||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,298 | ||
Total current assets: | 98,573 | 140,256 | 174,876 | 127,038 | 133,332 | 184,825 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 2,182 | 3,205 | 3,398 | 3,971 | 3,839 | 3,167 | |||
Long-term investments and receivables | 81,761 | 25,572 | 25,541 | ||||||
Long-term investments | 81,761 | 25,572 | 25,541 | ||||||
Other noncurrent assets | 7 | 34 | 112 | 31 | 115 | ✕ | |||
Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 546 | ||
Total noncurrent assets: | 2,189 | 3,239 | 3,510 | 85,763 | 29,526 | 29,254 | |||
TOTAL ASSETS: | 100,762 | 143,494 | 178,386 | 212,801 | 162,858 | 214,079 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 2,910 | 4,087 | 5,339 | 4,495 | 10,170 | 7,977 | |||
Employee-related liabilities | 2,533 | 2,705 | 3,272 | 2,568 | 3,066 | 2,427 | |||
Accounts payable | 376 | 1,382 | 1,263 | 1,235 | 5,435 | 3,648 | |||
Accrued liabilities | 804 | 693 | 1,669 | 1,903 | |||||
Debt | 13 | ||||||||
Other liabilities | 3 | 18 | |||||||
Deferred revenue and credits | ✕ | 50 | 59,747 | 51,993 | |||||
Other undisclosed current liabilities | 1,637 | 1,475 | 850 | 2,337 | 3,728 | 2,487 | |||
Total current liabilities: | 4,546 | 5,562 | 6,189 | 6,885 | 73,663 | 62,470 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 42 | ||||||||
Capital lease obligations | 42 | ||||||||
Liabilities, other than long-term debt | 732 | 785 | 850 | 912 | 965 | 51,993 | |||
Deferred revenue and credits | ✕ | 732 | 782 | 832 | 882 | 932 | 51,993 | ||
Other liabilities | 3 | 19 | 30 | 33 | |||||
Total noncurrent liabilities: | 732 | 785 | 850 | 912 | 965 | 52,035 | |||
Total liabilities: | 5,278 | 6,347 | 7,039 | 7,797 | 74,629 | 114,505 | |||
Equity | |||||||||
Equity, attributable to parent | 95,484 | 137,147 | 171,346 | 205,004 | 88,229 | 99,573 | |||
Common stock | 48 | 42 | 42 | 42 | 36 | 36 | |||
Additional paid in capital | 404,455 | 390,769 | 381,118 | 373,572 | 262,061 | 255,357 | |||
Accumulated other comprehensive income (loss) | (64) | (41) | (79) | (144) | 57 | 73 | |||
Accumulated deficit | (308,955) | (253,623) | (209,735) | (168,465) | (173,925) | (155,892) | |||
Total equity: | 95,484 | 137,147 | 171,346 | 205,004 | 88,229 | 99,573 | |||
TOTAL LIABILITIES AND EQUITY: | 100,762 | 143,494 | 178,386 | 212,801 | 162,858 | 214,079 |
Income Statement (P&L) ($ in thousands)
9/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 70 | 70 | 70 | 70,353 | 64,871 | 34,682 | ||
Revenue, net | ✕ | 20 | 52,720 | 13,420 | 7,220 | |||
Cost of revenue (Cost of Goods and Services Sold) | (51,600) | (27,500) | ||||||
Gross profit: | 70 | 70 | 70 | 70,353 | 13,271 | 7,182 | ||
Operating expenses | (56,176) | (44,790) | (42,043) | (65,327) | (83,213) | (50,725) | ||
Other undisclosed operating income | 51,600 | 27,500 | ||||||
Operating income (loss): | (56,106) | (44,720) | (41,973) | 5,027 | (18,342) | (16,043) | ||
Nonoperating income (expense) | 12 | (28) | 52 | 435 | 312 | (620) | ||
Investment income, nonoperating | 580 | 466 | 328 | |||||
Other nonoperating income (expense) | 12 | (28) | 52 | (145) | (154) | (948) | ||
Interest and debt expense | (1) | (2) | (1,621) | |||||
Income (loss) from continuing operations: | (56,094) | (44,749) | (41,921) | 5,461 | (18,032) | (18,284) | ||
Income (loss) before gain (loss) on sale of properties: | (56,094) | (44,749) | (41,921) | 5,461 | (18,032) | (18,284) | ||
Other undisclosed net income | 1,029 | |||||||
Net income (loss): | (55,064) | (44,749) | (41,921) | 5,461 | (18,032) | (18,284) | ||
Other undisclosed net income (loss) attributable to parent | 861 | 652 | (1) | 992 | ||||
Net income (loss) available to common stockholders, diluted: | (55,064) | (43,888) | (41,270) | 5,459 | (18,032) | (17,292) |
Comprehensive Income ($ in thousands)
9/30/2018 TTM | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (55,064) | (44,749) | (41,921) | 5,461 | (18,032) | (18,284) | ||
Other comprehensive income (loss) | 65 | (201) | (16) | |||||
Comprehensive income (loss): | (55,064) | (44,749) | (41,857) | 5,260 | (18,048) | (18,284) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (23) | 899 | 652 | (1) | 1,071 | |||
Comprehensive income (loss), net of tax, attributable to parent: | (55,087) | (43,849) | (41,205) | 5,259 | (18,048) | (17,213) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.